Table 2.
The distribution of clinic factors in relation to dichotomous status of SNCG expression.
| SNCG+ | SNCG− | p value | |
|---|---|---|---|
| FIGO grade | |||
| G1+2 | 17 (6) | 153 (55) | <0.001 |
| G3 | 40 (14) | 69 (25) | |
| Tumor subtype | <0.001 | ||
| USC (n=46)+CCC(n=14) | 29 (10) | 31 (11) | |
| Endometrioid | 23 (8) | 177 (63) | |
| Carcinosarcoma | 5 (2) | 14 (5) | |
| Depth of invasion | 0.031 | ||
| =<50% | 29 (10) | 148 (53) | |
| >50% | 28 (10) | 74 (27) | |
| Tumor stage | 0.032 | ||
| I+II | 38 (14) | 179 (64) | |
| III+IV | 19 (7) | 43 (15) | |
| LVI | <0.001 | ||
| Yes | 29 (10) | 49 (18) | |
| No | 28 (10) | 173 (62) | |
| Lymph nodes | 0.169 | ||
| Pos (51) | 15 (5) | 36 (13) | |
| Negative (151) | 29 (10) | 122 (44) | |
| Missing(77) | 13 (5) | 64 (23) | |
| Recurrence | 0.006 | ||
| Yes | 17 (6) | 27 (10) | |
| No | 38 (14) | 179 (64) | |
| Others | 2 (0.7) | 16 (6) | |
| Status | 0.006 | ||
| ANED | 34 (12) | 175 (63) | |
| All others | 23 (8) | 47 (17) | |